tirzepatide renal impairment 🧬 New data from the SUMMIT trial reveals that long-term (Zepbound) may Tirzepatide for Weight Loss with

Once a vial is first punctured, it should generally be used within 28 days unless the pharmacy label or manufacturer instructions state otherwise

Fatigue Some users report low energy during the adjustment period

Safety Monitoring Recommendations Based on the available clinical trial data, clinicians prescribing orforglipron should: (1) counsel patients about expected GI side effects during dose escalation, (2) follow the recommended dose-titration schedule to minimize GI intolerance, (3) monitor for signs of pancreatitis and discontinue if suspected, (4) assess hepatic and renal function at baseline and periodically, (5) screen for personal or family history of MTC or MEN 2, and (6) review concomitant medications for potential CYP3A-mediated drug interactions

Equity markets move on two things: earnings and liquidity

A lower all-cause dementia risk associated with SGLT2 inhibitors was found among those with atherosclerotic cardiovascular disease (HR [95% CI]: 0.80 [0.680.95]) and renal insufficiency (HR [95% CI]: 0.80 [0.650.99])

[6] [18] The standard titration schedule begins at 0.25 mg once weekly for four weeks (an initiation dose not intended for glycemic control), followed by escalation to 0.5 mg weekly